TAK-071, a muscarinic M1 receptor positive allosteric modulator, attenuates scopolamine-induced quantitative electroencephalogram power spectral changes in cynomolgus monkeys-Reference-Cited by-同舟云学术

TAK-071, a muscarinic M1 receptor positive allosteric modulator, attenuates scopolamine-induced quantitative electroencephalogram power spectral changes in cynomolgus monkeys

Published:2019-03-11 Issue:3 Volume:14 Page:e0207969
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kurimoto Emi,Nakashima Masato,Kimura Haruhide,Suzuki Motohisa^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference44 articles.

1. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease;R Schliebs;J Neural Transm (Vienna),2006

2. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development;AV Terry Jr.;J Pharmacol Exp Ther,2003

3. Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies;H Fujishiro;Acta Neuropathol,2006

4. M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update;A Fisher;Ann N Y Acad Sci,1996

5. The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease;NC Bodick;Alzheimer Dis Assoc Disord,1997

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern synthesis of cognitive enhancers: cholinergic ligands;Russian Chemical Bulletin;2023-04

2. FPT, a 2-Aminotetralin, Is a Potent Serotonin 5-HT_1A, 5-HT_1B, and 5-HT_1D Receptor Agonist That Modulates Cortical Electroencephalogram Activity in Adult Fmr1 Knockout Mice;ACS Chemical Neuroscience;2022-12-06

3. Opportunities and challenges for the development of M ₁ muscarinic receptor positive allosteric modulators in the treatment for neurocognitive deficits;British Journal of Pharmacology;2022-12-04

4. Muscarinic acetylcholine receptors for psychotic disorders: bench-side to clinic;Trends in Pharmacological Sciences;2022-12

5. Lamotrigine and retigabine increase motor threshold in transcranial magnetic stimulation at the dose required to produce an antiepileptic effect against maximal electroshock-induced seizure in rats;Neuroscience Letters;2022-02